ArticleBMJ paediatrics open2025
Machine learning-based risk prediction models for bronchopulmonary dysplasia in preterm infants: a high-altitude cohort study.
Article in BMJ paediatrics open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Artificial intelligence-guided nutritional therapy in the ICU.Current opinion in clinical nutrition and metabolic care · 2026Review
- The risk of developing severe bronchopulmonary dysplasia: evaluating associations with the nucleated red blood cell count at birth and volume of transfusions received.Frontiers in pediatrics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundBronchopulmonary dysplasia (BPD) is a significant cause of morbidity in preterm infants, yet its development and severity at high altitudes (>1500 m) remain poorly understood. This study aimed to identify altitude-specific risk factors and develop robust, interpretable predictive models for BPD in this unique population.
methodsIn this retrospective matched cohort study, 378 preterm infants (<32 weeks gestation, <1500 g birth weight) admitted to a high-altitude (1500 m) NICU(Neonatal Intensive Care Unit) between 2019 and 2023 were analysed. The cohort included 189 BPD cases (91 mild, 61 moderate, 37 severe) and 189 matched controls. Maternal, perinatal and postnatal data were collected. Machine learning models (XGBoost, logistic regression, random forest) were developed and rigorously evaluated using comprehensive performance metrics to predict BPD occurrence and severity. SHAP (SHapley Additive exPlanations) analysis was employed to interpret the best-performing model.
resultsKey risk factors for BPD development included maternal hypertension (OR 2.31, 95% CI 1.56 to 3.42), initial oxygen requirement >30% (OR 3.15, 95% CI 2.13 to 4.65) and lack of exclusive breast milk feeding (OR 1.89, 95% CI 1.28 to 2.79). Severe BPD was independently associated with prolonged invasive ventilation (>7 days) (OR 4.12, 95% CI 2.78 to 6.11), elevated C reactive protein (>10 mg/L) (OR 2.87, 95% CI 1.93 to 4.26) and patent ductus arteriosus (OR 2.53, 95% CI 1.71 to 3.74). Machine learning models demonstrated strong predictive performance; the optimal XGBoost model achieved an area under the curve of 0.89 (95% CI 0.85 to 0.93), an F1 score of 0.82, a Matthews Correlation Coefficient of 0.73 and a balanced accuracy of 0.85. SHAP analysis identified initial FiO2 >30%, mechanical ventilation and maternal hypertension as the top three most influential predictors for the XGBoost model.
conclusionsThis study provides the first comprehensive analysis of BPD risk factors at a specific high altitude and validates effective, interpretable machine learning models for its prediction. These findings highlight the critical importance of altitude-specific adjustments in risk assessment and emphasise the potential for model-guided early interventions to improve outcomes for this vulnerable population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.